Diabetes Care 27:2960-2965, 2004
© 2004 by the American Diabetes Association, Inc.
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes Original Article |
Association Between Inflammation and Insulin Resistance in U.S. Nondiabetic Adults
Results from the Third National Health and Nutrition Examination Survey
Jing Chen, MD, MSC1,2,
Rachel P. Wildman, PHD2,
L. Lee Hamm, MD1,
Paul Muntner, PHD1,2,
Kristi Reynolds, MPH1,
Paul K. Whelton, MD, MSC1,2 and
Jiang He, MD, PHD1,2
1 Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana
2 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana
Address correspondence and reprint requests to Jing Chen, MD, MSc, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Ave., SL45, New Orleans, LA 70112. E-mail: jchen{at}tulane.edu
Clinical and epidemiological data indicate that inflammation may be associated with insulin resistance. We examined the association between inflammatory markers, such as ferritin, uric acid, white cell counts, fibrinogen, and C-reactive protein, and insulin resistance among 5,959 adults, aged 20 years and without diabetes (fasting glucose <126 mg/dl and not taking diabetes medication), who participated in the Third National Health and Nutrition Examination Survey. Insulin resistance was calculated using the homeostasis model assessment (HOMA). Levels of ferritin, uric acid, white cell counts, fibrinogen, and C-reactive protein were significantly higher in individuals with a higher HOMA of insulin resistance (HOMA-IR). After adjustment for age, sex, race, education, physical inactivity, current and former smoking, alcohol intake, use of nonsteroidal anti-inflammatory drugs, systolic blood pressure, BMI, waist circumference, serum total cholesterol, and triglycerides, a 1-SD higher ferritin (126.1 ng/ml), uric acid (1.4 mg/dl), white blood cell count (2.2 x 109/l), and fibrinogen (80.6 mg/dl) was associated with a 0.10 (95% CI 0.030.17, P = 0.004), 0.16 (0.080.24, P < 0.001), 0.16 (0.090.22, P < 0.001), and 0.12 (0.050.18, P = 0.001) higher HOMA-IR, respectively. Clinically elevated C-reactive protein ( 1.0 mg/dl) was associated with a 0.63 (0.231.04, P = 0.003) higher HOMA-IR. These findings indicate that elevated levels of inflammatory markers are positively and independently associated with insulin resistance. Further studies should examine the potential causal effect of inflammation on insulin resistance.
Abbreviations: GFR, glomerular filtration rate HOMA, homeostasis model assessment HOMA-IR, HOMA of insulin resistance NHANES III, Third National Health and Nutrition Examination Survey NSAID, nonsteroidal anti-inflammatory drug

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. L. Pande, T. S. Perlstein, J. A. Beckman, and M. A. Creager
Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease: The National Health and Nutrition Examination Survey, 1999 to 2004
Circulation,
July 1, 2008;
118(1):
33 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I. P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, and R. J. Johnson
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
Am J Physiol Renal Physiol,
April 1, 2008;
294(4):
F710 - F718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S.H. Bell and J. H. O'Keefe
White Cell Count, Mortality, and Metabolic Syndrome in the Baltimore Longitudinal Study of Aging
J. Am. Coll. Cardiol.,
October 30, 2007;
50(18):
1810 - 1810.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Porrini, M. D. Gomez, A. Alvarez, M. Cobo, J. M. Gonzalez-Posada, L. Perez, L. Hortal, J. J. Garcia, M. Dolores Checa, A. Morales, et al.
Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes
Nephrol. Dial. Transplant.,
July 1, 2007;
22(7):
1994 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Jehn, E. Guallar, J. M. Clark, D. Couper, B. B. Duncan, C. M. Ballantyne, R. C. Hoogeveen, Z. L. Harris, and J. S. Pankow
A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Am. J. Epidemiol.,
May 1, 2007;
165(9):
1047 - 1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Markus, R. Labrum, S. Bevan, M. Reindl, G. Egger, C. J. Wiedermann, Q. Xu, S. Kiechl, and J. Willeit
Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis
Stroke,
September 1, 2006;
37(9):
2253 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Citrome
Metabolic Syndrome and Cardiovascular Disease
J Psychopharmacol,
November 1, 2005;
19(6_suppl):
84 - 93.
[Abstract]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|